Jingyu Xiang
Jingyu Xiang
Geverifieerd e-mailadres voor wustl.edu
Geciteerd door
Geciteerd door
Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment
E Heller, MA Hurchla, J Xiang, X Su, S Chen, J Schneider, KS Joeng, ...
Cancer research 72 (4), 897-907, 2012
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling
X Su, DH Floyd, A Hughes, J Xiang, JG Schneider, O Uluckan, E Heller, ...
The Journal of clinical investigation 122 (10), 3579-3592, 2012
Antagonizing integrin β3 increases immunosuppression in cancer
X Su, AK Esser, SR Amend, J Xiang, Y Xu, MH Ross, GC Fox, ...
Cancer research 76 (12), 3484-3495, 2016
CXCR4 protein epitope mimetic antagonist POL5551 disrupts metastasis and enhances chemotherapy effect in triple-negative breast cancer
J Xiang, MA Hurchla, F Fontana, X Su, SR Amend, AK Esser, GJ Douglas, ...
Molecular cancer therapeutics 14 (11), 2473-2485, 2015
Noncompetitive Modulation of the Proteasome by Imidazoline Scaffolds Overcomes Bortezomib Resistance and Delays MM Tumor Growth in Vivo
TA Lansdell, MA Hurchla, J Xiang, S Hovde, KN Weilbaecher, RW Henry, ...
ACS chemical biology 8 (3), 578-587, 2013
JARID2 functions as a tumor suppressor in myeloid neoplasms by repressing self-renewal in hematopoietic progenitor cells
H Celik, WK Koh, AC Kramer, EL Ostrander, C Mallaney, DAC Fisher, ...
Cancer cell 34 (5), 741-756. e8, 2018
Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model
AK Esser, AH Schmieder, MH Ross, J Xiang, X Su, G Cui, H Zhang, ...
Nanomedicine: Nanotechnology, Biology and Medicine 12 (1), 201-211, 2016
HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice
AK Esser, DA Rauch, J Xiang, JC Harding, NA Kohart, MH Ross, X Su, ...
Oncotarget 8 (41), 69250, 2017
Evaluating acetate metabolism for imaging and targeting in multiple myeloma
F Fontana, X Ge, X Su, D Hathi, J Xiang, S Cenci, R Civitelli, KI Shoghi, ...
Clinical Cancer Research 23 (2), 416-429, 2017
Mouse model recapitulates the phenotypic heterogeneity of human adult T-cell leukemia/lymphoma in bone
NA Kohart, SM Elshafae, W Supsahvad, A Alasonyalilar-Demirer, ...
Journal of Bone Oncology 19, 100257, 2019
Parathyroid hormone-related protein promotes bone loss in T-cell leukemia as well as in solid tumors
NA Kohart, SM Elshafae, AA Demirer, WP Dirksen, JT Breitbach, ST Shu, ...
Leukemia & Lymphoma 61 (2), 409-419, 2020
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer
AK Esser, MH Ross, F Fontana, X Su, A Gabay, GC Fox, Y Xu, J Xiang, ...
Theranostics 10 (17), 7510, 2020
HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia
J Xiang, DA Rauch, DD Huey, AR Panfil, X Cheng, AK Esser, X Su, ...
JCI insight 4 (19), 2019
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–13